Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Skye Bioscience Inc’s stock clocked out at $3.69, up 1.93% from its previous closing price of $3.62. In other words, the price has increased by $1.93 from its previous closing price. On the day, 2.05 million shares were traded.
Ratios:
To gain a deeper understanding of SKYE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.85 and its Current Ratio is at 11.85. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On September 30, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $20.
On September 10, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $15.JMP Securities initiated its Mkt Outperform rating on September 10, 2024, with a $15 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 18 ’24 when Diep Tuan Tu sold 19,489 shares for $4.99 per share. The transaction valued at 97,250 led to the insider holds 82,259 shares of the business.
Diep Tuan Tu sold 85 shares of SKYE for $472 on Nov 15 ’24. The Chief Development Officer now owns 101,748 shares after completing the transaction at $5.55 per share. On Nov 18 ’24, another insider, ARSENAULT KAITLYN, who serves as the Chief Financial Officer of the company, sold 43,206 shares for $4.99 each. As a result, the insider received 215,598 and left with 166,342 shares of the company.
Stock Price History:
Over the past 52 weeks, SKYE has reached a high of $8.44, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is 78.16%, while the 200-Day Moving Average is calculated to be 16.68%.
Shares Statistics:
A total of 30.97M shares are outstanding, with a floating share count of 17.86M. Insiders hold about 42.35% of the company’s shares, while institutions hold 41.37% stake in the company.
